Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer

Targeting AFP in hepatocellular cancer

Combination of viroimmunotherapy with checkpoint inhibitors

The role of microRNAs in modulation of the immune escape of tumors

T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy

Immunotherapy and personalised medicine in review

Treating childhood brainstem cancer using nanotechnology

Molecular drug imaging to guide brain cancer therapy

Complementary drug delivery techniques for interstitial administration

Editor's choice for January 2016

Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs everolimus for RCC

Discontinuing VEGF-targeted therapy for progression or toxicity affects outcomes of second-line therapies in mRCC